Authors
1
Alkhadhmia paediatric hospital , Baghdad
2
medical collage university of baghdad
3
clinical immunology
,
Document Type : Research Paper
Abstract
Background: Children with epilepsy have a high burden of physical comorbidity, and they experience poor long-term medical outcomes even after remission of their epilepsy. Little is known about types of these comorbidities and their occurrence in children epilepsy in Iraq.
Objectives: the aim of this study to assess bone and growth status in children with epilepsy.
Patients and methods: a cross sectional case-control study was conducted in Children Welfare Teaching Hospital, in the period from November 2018 to October 2019. The study included 40 children diagnosed with epilepsy and another 40 healthy children, age- and sex-matched. The following parameters were measured in both groups: body weight, height, body mass index (BMI), bone mineral density (BMD) and vitamin D level.
Results: In the epileptic children group, 28(70%) males and 12 (30%) females were reported. The predominant epilepsy type was focal 30children (75%). Among the epileptic children. Sixteen (40%) epileptic patients were placed on monotherapy treatment, while 24 (60%) were placed on polytherapy The level of Alkaline Phosphatase and phosphorus level was significantly higher in epileptic patients than in controls while there were no significant difference in calcium levels between patients and control groups. On the other hand, vitamin D found to be lower in epilepsy children with statistical significance. The growth parameters (weight, height and body mass index)show no significance between patent and control groups, The standard normal distribution(Z-score)of DXA scan also show no significance in both groups.
Conclusion: The children with epilepsy and on treatment with AEDs are at higher risk of hypovitaminosis D, There were no significant radiological changes (measured by DXA scan) in the epileptic children placed on AEDs for at least one year, in comparison to the healthy children.
- The global burden of disease: 2004 update. Geneva, World Health Organization, 2004 (http://www.who.int/healthinfo/global_burden_disease/2004_report_ update/en/index.html, accessed 22 January 2010).
- Reynolds EH. The ILAE/IBE/WHO epilepsy global campaign history. International League against Epilepsy and International Bureau for Epilepsy. Epilepsia, 2002; 43:9–11.
- Wei SH, Lee WT. Comorbidity of childhood epilepsy, J Formos Med Assoc. 2015;114:1031-38.
- Cunningham JL, Fordham JN, Hewitt TA,Speed CA. Ultrasound velocity and attenuation at different skeletal sites compared with bone mineral density measured using energy X-ray absorptiometry. BrJ Radiol 1996;69:25-32.
- Binkovitz LA, Henwood MJ, Sparke P. Pediatric dual-energy x- ray absorptiometry: technique, interpretation, and clinical applications. Semin Nucl Med 2007;37:303-13.
- El-Khayat HA, Aly GS, Tomoum HY, Mamdouh RM, Al-Badani AK, Mohamed EI. Growth hormone levels in children and adolescents with epilepsy. Eur J Paediatr Neurol. 2010;14: 508e12.
- Guide for Vitamin D in childhood. 2013 available from: http://www.rcpch.ac.uk/system/files/protected/page/vitdguidancedraftsprea ds%20FINAL%20for%20website.pdf..
- Lewiecki EM, Binkley N, Morgan SL,Shuhart CR, Camargos BM and International Society for Clinical Densitometry, et al. Best practices for dual-energy x ray absorptiometry measurement and reporting: international society for clinical densitometry guidance. J Clin Densitom 2016; 19:127–40
- Osman NM, Abdel Aziz RA, Soliman GT and Mohamed AG. Bone mineral density evaluation o epileptic children on anti- epileptic medications.Egyptian journal of radiology and nuclear medicine (online) 2017:1084-90.
- Paticheep S, Chotipanich C, Khusiwilai K,Wichaporn A, Khongsaengdao S. Antiepileptic drugs and bone health in Thai children with epilepsy. J Med Assoc Thai 2015; 98:535–41.
- Abdel Maksoud HM, El-Shazly SM and El Saied MH. Effect of antiepileptic drug (valproic acid) on children growth, Egyptian Pediatric Association Gazette, May 2016; 64:69–73.
- Nevitt SJ, Sudell M, Weston J, Smith CT, and Marson AG. Antiepileptic drug monotherapy for epilepsy: a network metanalysis of individual participant data.Cochrance database syst Rev. 2017;12:CD011412.
- Baek JH, Seo YH, Kim GH, Kim MK and Eun BL. Vitamin D Levels in Children and Adolescents with Antiepileptic Drug Treatment. Yonsei Med J. 2014 ;55: 417-21.
- Kadhum RH and Habeeb SI.25-Hydroxy vitamin D level in children with epilepsy in Basra, international journal of current research, 2017 ;9: 57788-92.
- Shih FU, Chuang YC, Chuang MJ, Lu YT, Tsai WC, Fu TY et al. Effects of antiepileptic drugs on thyroid hormone function in epilepsy patients, Seizure. 2017; 48:7-10.
- Razazizan N, Mirmoeini M, Daeichin S, Ghadiri Comparison of 25-Hydroxy Vitamin D, Calcium and Alkaline Phosphatase Levels in Epileptic and Non-Epileptic Children. Acta Neurol Taiwan. Sep 2013;22 :112-16.
- Babayigit A, Dirik E, Bober E, Cakmakci H. Adverse effects antiepileptic drugs on bone mineral Pediatr Neurol.Sep 2006;35:177-81.
- Alison P. The association between antiepileptic drugs and bone Disease. Epilepsy Curr. 2003; 3:91-95.
- Silvana F, Guerreiro CA, Magna Marques Neto Bone mineral density, vitamin D and anticonvulsant therapy. Arq Neuropsiquiatr. 2000; 58:616-620.
- Hasaneen B, Elsayed RM, Salem N, Elsharkawy A, Tharwat N, Fathy K, et al. Bone mineral status in children with epilepsy: Biochemical and radiologic markers. J Pediatr Neurosci 2017; 12:138-43.
- El-Hajj Fuleihan G, Dib L, Yamout B, Sawaya R, Mikati MA. Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone.Jul 2008;43:149–55.
- Zhang Ying, Zheng Yu-Xin, Zhu J-Ming. Effects of antiepileptic drugs on bone mineral density and bone metabolism in children: a meta-analysis. Zhang et al./J Zhejiang Univ-Sci B. Biomed Biotechnol. Jul 2015;16:611–21.
- Dimic´ M, Dimic´ A, Milosevic´ Z, et Bone mineral density in children with long-term antiepileptic therapy. Srp Arh Celok Lek.May-Jun 2013;141:329–32.
- Coppola G, Fortunato D, Auricchio G, et Bone mineral density in children,adolescents, and young adults with epilepsy. Epilepsia 2009; 50:2140–46.
- Vestergaard P. Effects of antiepileptic drugs on bone health and growth potential in children with epilepsy. Paediatr Drug 2015;17:141–50.
- Menon B.and Harinarayan C V. The effect of anti-epileptic drug therapy on serum 25 hydroxyl vitamin D and parameters of calcium and bone metabolism a longitudinal Seizure. 2010;19:153-58.
- Misra A, Aggarwal A, Singh O. Sharma S. Effect of carbamazepine therapy on vitamin D and parathormone in epileptic children. Pediatr Neurol 2010;43:320–24.
- Dong N, Guo HL, Hu YH, Yang J, Xu M, Ding L, et al. Association between serum vitamin D status and the anti-seizure treatment in Chinese children with epilepsy. Frontiers in Nutrition,2022:1-17. 10.3389/front.2022.968868.
- Kim SH, Lee JW, Chung HW, Lee A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. 2007;10:213-348.
Min L, Chunyan W & Biaoxue R. Effects of valproic acid on skeletal metabolism in children with epilepsy: A systematic evaluation and metaanalysis based on 14 studies. BMC Pediatrics, 2020; 20:97. 2-12. https://doi.org/10.1186/s12887-020-1984-7.